On February 6, 2026, Redwood AI Corp. (formerly Marshall Technologies Corp.) completed its initial public offering and listed its common shares for trading on the Canadian Securities Exchange under the symbol "AIRX." The listing was effected pursuant to a long-form prospectus dated January 30, 2026, which the company filed with the Alberta Securities Commission, the British Columbia Securities Commission, and the Ontario Securities Commission, and which is available under the company's profile on SEDAR+. In connection with the listing, the company also granted an aggregate of 1,850,000 restricted share units and 50,000 stock options to certain directors and consultants under its equity incentive plan, all subject to applicable resale restrictions and a hold period of four months and one day in accordance with applicable securities laws and stock exchange policies. Redwood AI is a Vancouver-based artificial intelligence company providing software and analytics solutions for chemical and pharmaceutical development. Its platform integrates AI models, cheminformatics, and operational data to support synthesis planning, process optimization, and supply-chain decision-making, with applications spanning pharmaceutical development, biotechnology, and material sciences. The company has a strategic collaboration with the University of British Columbia targeting AI-driven drug discovery for Alzheimer's disease, and has subsequently expanded its public profile through an OTCQB cross-listing under the symbol RDWCF and a Frankfurt Stock Exchange listing under the symbol Y0N (WKN: A422EZ). The IPO marked the company's transition from a privately held capital pool / shell-style technology vehicle (previously Marshall Technologies Corp., incorporated in 2022) to a publicly traded reporting issuer with a focused commercial mandate in AI-enabled chemistry.